Adolescent and youthful adult (AYA) individuals with hematological malignancy older 15 to 39 years are named another entity, as well as the efficacy and safety of unrelated cord bloodstream transplantation (CBT) for chronic myeloid leukemia (CML) in AYA individuals is not reported. similar pursuing CBT and sibling-PBSCT/BMT. The cumulative incidences of cGVHD and considerable cGVHD… Continue reading Adolescent and youthful adult (AYA) individuals with hematological malignancy older 15